MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹6,986 Cr | ₹6,566 Cr | ₹4,325 Cr | ₹4,404 Cr | ₹3,880 Cr |
What is the latest Total Current Assets ratio of MANKIND PHARMA ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹6,986 Cr |
| Mar2024 | ₹6,566 Cr |
| Mar2023 | ₹4,325 Cr |
| Mar2022 | ₹4,404 Cr |
| Mar2021 | ₹3,880 Cr |
How is Total Current Assets of MANKIND PHARMA Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,986 Cr | 6.40 | |
| Mar2024 | ₹6,566 Cr | 51.82 | |
| Mar2023 | ₹4,325 Cr | -1.80 | |
| Mar2022 | ₹4,404 Cr | 13.51 | |
| Mar2021 | ₹3,880 Cr | - | |
Compare Total Current Assets of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,376.4 Cr | 1.5% | 8.7% | -5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.5% |
8.7% |
-5% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses